MedTrace Logo

FAST (Focused Abbreviated Screening Technique)-MRI Study

NCT04539717 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 820

Last updated 2025-10-08

No results posted yet for this study

Summary

The purpose of this study is to compare the diagnostic value of a reconstructed abbreviated Magnetic Resonance Imaging (MRI) from a full clinical exam, compared to ultrasound (US) for screening of liver cancer. Blood markers will be evaluated to determine their correlation to imaging. This study will help to determine whether abbreviated MRI is superior to ultrasound for diagnosis of liver cancer.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Bachir Taouli · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-17
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04539717 on ClinicalTrials.gov